Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 297, Issue 5, 2009, Pages

  Pfeil, Uwe ^a   Aslam, Muhammad ^b   Paddenberg, Renate ^a   Quanz, Karin ^b   Chang, Chia L ^c   Park, Jae Il ^d   Gries, Barbara ^a   Rafiq, Amir ^a   Faulhammer, Petra ^a   Goldenberg, Anna ^a   Papadakis, Tamara ^a   Noll, Thomas ^b   Hsu, Sheau Y T ^e   Weissmann, Norbert ^b   Kummer, Wolfgang ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Edema; Endothelial permeability

Indexed keywords

ADRENOMEDULLIN; INTERMEDIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL CULTURE; CELL HYPOXIA; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; IMMUNOHISTOCHEMISTRY; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADRENOMEDULLIN; ANIMALS; CAPILLARY PERMEABILITY; CELL ADHESION MOLECULES; CELL HYPOXIA; ENDOTHELIAL CELLS; HUMANS; LUNG; MICE; MICROFILAMENT PROTEINS; NEUROPEPTIDES; NIH 3T3 CELLS; PEPTIDE HORMONES; PEPTIDES; PHOSPHOPROTEINS; PHOSPHOSERINE; PRESSURE; PROMOTER REGIONS, GENETIC; SUBCELLULAR FRACTIONS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 72449200648     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90608.2008     Document Type: Article

References (46)

1. Abdelrahman AM, Pang CC. Vasodilator mechanism of intermedin/ adrenomedullin-2 in anesthetized rats. Proc West Pharmacol Soc 50: 43-46, 2007.
2. Bell D, McDermott BJ. Intermedin (adrenomedullin-2): a novel counterregulatory peptide in the cardiovascular and renal systems. Br J Pharmacol 153: 247-262, 2008.
3. Berg JT, Ramanathan S, Swenson ER. Inhibitors of hypoxic pulmonary vasoconstriction prevent high-altitude pulmonary edema in rats. Wilderness Environ Med 15: 32-37, 2004. (Pubitemid 38326087)
4. Bogatcheva NV, Garcia JGN, Verin AD. Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry 67: 75-84, 2002.
5. Burak Kandilci H, Gumusel B, Wasermann A, Witriol N, Lippton H. Intermedin/adrenomedullin-2 dilates the rat pulmonary vascular bed: dependence on CGRP receptors and nitric oxide release. Peptides 27: 1390-1396, 2006. (Pubitemid 43766994)
6. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 269: 14509-14517, 1994. (Pubitemid 24194005)
7. Carpenter TC, Stenmark KR. Hypoxia decreases lung neprilysin expression and increases pulmonary vascular leak. Am J Physiol Lung Cell Mol Physiol 281: L941-L948, 2001. (Pubitemid 33781078)
8. Chakravarty P, Suthar TP, Coppock HA, Nicholl CG, Bloom SR, Legon S, Smith DM. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br J Pharmacol 130: 189-195, 2000. (Pubitemid 30248444)
9. Chang CL, Roh J, Hsu SYT. Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin/intermedin family peptides in vertebrates. Peptides 25: 1633-1642, 2005. (Pubitemid 39346205)
10. Chen L, Kis B, Hashimoto H, Busija DW, Takei Y, Yamashita H, Ueta Y. Adrenomedullin 2 protects rat cerebral endothelial cells from oxidative damage in vitro. Brain Res 1086: 42-49, 2006.
11. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J 16: 583-585, 2002.
12. Dehler M, Zessin E, Bärtsch P, Maierbäuerl H. Hypoxia causes permeability oedema in the constant-pressure perfused rat lung. Eur Respir J 27: 600-606, 2006. (Pubitemid 43372536)
13. Forsythe JA, Bing-hua J, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996. (Pubitemid 26272112)
14. Fujisawa Y, Nagai Y, Miyatake A, Miura K, Nishiyama A, Kimura S, Abe Y. Effects of adrenomedullin 2 on regional hemodynamics in conscious rats. Eur J Pharmacol 558: 128-132, 2007. (Pubitemid 46328879)
15. Fujisawa Y, Nagai Y, Miyatake A, Miura K, Shokoji T, Nishiyama A, Kimura S, Abe Y. Roles of adrenomedullin 2 in regulating the cardiovascular and sympathetic nervous system in conscious rats. Am J Physiol Heart Circ Physiol 290: H1120-H1127, 2006.
16. Garayoa M, Martinez A, Lee S, Pio R, An WG, Neckers L, Trepel J, Montuenga LM, Ryan H, Johnson R, Gassamnn M, Cuttitta F. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol 14: 848-862, 2000.
17. Halstead SB. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 4: 830-839, 1989.
18. Hamid SA, Baxter GF. Adrenomedullin limits reperfusion injury in experimental myocardial infarction. Basic Res Cardiol 100: 387-396, 2005. (Pubitemid 41300493)
19. Hippenstiel S, Witzenrath M, Schmeck B, Hocke A, Krisp M, Krull M, Seybold J, Seeger W, Rascher W, Schutte H, Suttrop N. Adrenomedullin reduces endothelial hyperpermeability. Circ Res 91: 618-625, 2002.
20. Hocke AC, Temmesfeld-Wollbrueck B, Schmeck B, Berger K, Frisch EM, Witzenrath M, Brell B, Suttrop N, Hippenstiel S. Perturbation of endothelial junction proteins by Staphylococcus aureus alpha-toxin: inhibition of endothelial gap formation by adrenomedullin. Histochem Cell Biol 126: 305-316, 2006. (Pubitemid 44239144)
21. Insel PA, Ostrom RS. Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol 23: 305-314, 2003.
22. Kadl A, Leitinger N. The role of endothelial cells in the resolution of acute inflammation. Antioxid Redox Signal 11-12: 1744-1754, 2005. (Pubitemid 41768006)
23. Kandilci HB, Gumusel B, Lippton H. Intermedin/adrenomedullin-2 (IMD/AM2) relaxes rat main pulmonary arterial rings via cGMP-dependent pathway: role of nitric oxide and large conductance calcium-activated potassium channels (BKCa). Peptides 29: 1321-1328, 2008.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
25. Li YS, Haga JH, Chien S. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech 38: 1949-1971, 2005.
26. Lips KS, Pfeil U, Reiners K, Rimasch C, Kuchelmeister K, Braun- Dullaeus RC, Haberberger RV, Schmidt R, Kummer W. Expression of the high-affinity choline transporter CHT1 in rat and human arteries. J Histochem Cytochem 51: 1645-1654, 2003. (Pubitemid 37475437)
27. Mairbäurl H. Role of alveolar epithelial sodium transport in high altitude pulmonary edema (HAPE). Respir Physiol Neurobiol 151: 178-191, 2006.
28. Noll T, Wozniak G, McCarson K, Hajimohammad A, Metzner HJ, Inserte J, Kummer W, Hehrlein FE, Piper HM. Effect of factor XIII on endothelial barrier function. J Exp Med 189: 1373-1382, 1999. (Pubitemid 29227523)
29. Ogunrinade O, Kameya GT, Truskey GA. Effect of fluid shear stress on the permeability of the arterial endothelium. Ann Biomed Eng 30: 430-446, 2002. (Pubitemid 34726332)
30. Peters CJ, Zaki SR. Role of endothelium in viral hemorrhagic fevers. Crit Care Med 30: 268-273, 2002.
31. Pfeil U, Paddenberg R, Kummer W. Mitochondrial regulation of hypoxia- induced increase of adrenomedullin mRNA in HL-1 cells. Biochem Biophys Res Commun 343: 885-892, 2006.
32. Qing X, Svaren J, Keith IM. mRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lung. Am J Physiol Lung Cell Mol Physiol 280: L547-L554, 2001. (Pubitemid 32473206)
33. Roh J, Chang CL, Bhalla A, Klein C, Hsu SYT. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 279: 7264-7274, 2004. (Pubitemid 38248876)
34. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269: 23757-23763, 1994.
35. Shih SC, Claffey KP. Hypoxia-mediated regulation of gene expression in mammalian cells. Int J Exp Pathol 79: 347-357, 1998. (Pubitemid 29010694)
36. Szekanecz Z, Koch AE. Vascular endothelium and immune responses: implications for inflammation and angiogenesis. Rheum Dis Clin North Am 30: 97-114, 2004. (Pubitemid 38234770)
37. Takei Y, Inoue K, Ogoshi M, Kawahara T, Bannai H, Miyano S. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett 556: 53-58, 2004. (Pubitemid 38058554)
38. Taylor AE. Pulmonary edema: ischemia reperfusion endothelial injury and its reversal by c-AMP. Proc Natl Sci Counc Repub China B 15: 191-195, 1991.
39. Taylor MM, Bagley SL, Samson WK. Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake. Am J Physiol Regul Integr Comp Physiol 288: R919-R927, 2005.
40. Ten VS, Pinsky DJ. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 8: 242-250, 2002.
41. Weissmann N, Manz D, Buchspies D, Keller S, Mehling T, Voswinckel R, Quanz K, Ghofrani HA, Schermuly RT, Fink L. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia. Thromb Haemost 94: 630-638, 2005.
42. Weissmann N, Quanz K, Schermuly RT, Ghofrani HA, Fink L, Hänze J, Rose F, Seeger W, Grimminger F. Basic features of hypoxic pulmonary vasoconstriction in mice. Respir Physiol Neurobiol 139: 191-202, 2004. (Pubitemid 38281122)
43. Yang JH, Jia YX, Pan CS, Zhao J, Ouyang M, Yang J, Chang JK, Tang CS, Qi YF. Effects of intermedin(1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts. Biochem Biophys Res Commun 327: 713-719, 2005. (Pubitemid 40092808)
44. Yang BC, Lippton H, Gumusel B, Hyman A, Metha JL. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins. J Cardiovasc Pharmacol 28: 458-462, 1996. (Pubitemid 26317446)
45. Zhang SX, Miller JJ, Stolz DB, Serpero LD, Zhao W, Gozal D, Wang Y. Type I epithelial cells are the main target of whole-body hypoxic preconditioning in the lung. Am J Respir Cell Mol Biol 40: 332-339, 2009.
46. Zimmermann U, Fischer JA, Muff R. Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells. Peptides 16: 421-424, 1995.